Freenome swings to Q3 net profit of $60.11 million; Q3 revenue rises to $183.49 million
Bitget2026/11/10 21:05- Freenome swung to GAAP net income of $60.1 million in the third quarter of 2026 from a year-earlier loss.
- Revenue rose to $183.5 million from a year earlier, driven primarily by collaboration payments following FDA approval of SimpleScreen CRC.
- Abbott launched SimpleScreen CRC in the United States on September 30, 2026, under the commercial license agreement.
- Full-year 2026 revenue is expected to reach $192 million to $194 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Blackstone (BX.US) injects up to $1.5 billion, providing fresh ammunition for Pfizer (PFE.US) in the weight-loss drug race
Pfizer announced on Wednesday that it has reached an agreement with Blackstone to obtain up to $1.5 billions in funding to support the development of its experimental monthly obesity treatment drug.
Bernstein Downgrades Nvidia Rating and Target Price
Google (GOOGL.US) DeepMind launches AlphaGenome 2: Capable of decoding DNA cells with nearly double the mutation identification capacity
Google DeepMind has released its AI model AlphaGenome 2, which is trained on maps of over 100 millions of cells and has nearly double the ability of its predecessor in identifying gene expression variations.
The White House did not intervene in the decision-making of Nvidia's board of directors.
Crypto prices
More
